Case Studies, Pharmaceutical

Case Study – Unidose Nasal Spray Pump in Hypoglycemia

The conventional rescue medicine for hypoglycemia is an intramuscular injection of glucagon which must be reconstituted at point of use. This case study describes a collaborative drug repurposing project with Aptar Pharma culminating in the development of a glucagon nasal powder, an easier to administer alternative. The product utilizes Aptar Pharma’s patented Unidose Powder (UDS) System, is easy-to-store, and has a shelf-life of two years from manufacture. It provides diabetes patients with a highly effective rescue medicine that can be administered by a range of potential carers. Success rates with the nasal powder have been shown to exceed those with injectable glucagon and the product’s market value is expected to exceed $150 million by 2025.

Download Case Study - Unidose Nasal Spray pump in hypoglycemia
8 Sep 2022

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More About nasal drug delivery expertise

This Might Also Be of Interest

12 May 2020

Drug Delivery Systems & Services for Lifecycle Management of Crisis Medications ...

Webinars, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Product Solutions

Read More
1 May 2020

Supporting Improved Patient Onboarding and Adherence with Training Solutions

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions

Read More
21 Apr 2020

Using in vitro dissolution tests for local bioequivalence in OINDPs

Webinars, Pharmaceutical, Innovation & Insights, Market Insights

Read More
1 Apr 2020

Demonstrating bioequivalence in generic orally inhaled drug products

Publications, Pharmaceutical, Innovation & Insights

Read More
1 20 21 22 23 24 25

Request Access

Close

Requesting access to Case Study – Unidose Nasal Spray Pump in Hypoglycemia.

  • This field is for validation purposes and should be left unchanged.
Back To Top